FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1581947446> ?p ?o ?g. }

• W1581947446 endingPage "495" @default.
• W1581947446 startingPage "495" @default.
• W1581947446 abstract "To treat patients with stage I-IV malignant tumors of digestive tract using autologous tumor cell vaccine and NDV (Newcastle disease virus) vaccine, and observe the survival period and curative effect.335 patients with malignant tumors of digestive tract were treated with autologous tumor cell vaccine and NDV vaccine. The autologous tumor cell vaccine received were assigned for long-term survival observation. While these failed to obtain the autologous tumor tissue were given with NDV vaccine for a received short-term observation on curative effect.The colorectal cancer patients treated with autologous tumor cell vaccine were divided into two groups: the controlled group (subjected to resection alone) (n=257), the vaccine group (subjected to both resection and immunotherapy) (n=310). 25 patients treated with NDV immunotherapy were all at stage IV without having resection. In postoperation adjuvant therapy patients, the 5, 6 and 7-year survival rates were 66.51 %, 60.52 %, 56.50 % respectively; whereas in patients with resection alone, only 45.57 %, 44.76 % and 43.42 % respectively. The average survival period was 5.13 years (resection alone group 4.15 years), the median survival period was over 7 years (resection alone group 4.46 years). There were significant differences between the two groups. The patients treated with resection plus vaccine were measured delayed-type hypersensitivity (DTH) reactions after vaccination, (indurative scope >5 mm). The magnitude of DTH was related to the prognosis. The 5-year survival rate was 80 % for those with indurations greater than 5 mm, compared with 30 % for those with indurations less than 5 mm. The 1-year survival rate was 96 % for 25 patients treated with NDV immunotherapy. The total effective rate (CR+PR) was 24.00 % in NDV immunotherapy; complete remission (CR) in 1 case (4.00 %), partial remission (PR) in 5 cases (20.00 %), stabilizedin in 16 cases (64.00 %), progression (PD) in 1 case (4.00 %). After NDV vaccine immunotherapy, the number of NK cell increased and immune function imporved obviously.The autologous tumor cell vaccine and NDV vaccine can prolong the patients' life. NDV vaccine is notably effective for short-term with promotion of quality of life and can be used whenever necessary with good prospects." @default.
• W1581947446 created "2016-06-24" @default.
• W1581947446 creator A5016514981 @default.
• W1581947446 creator A5020302124 @default.
• W1581947446 creator A5026731219 @default.
• W1581947446 creator A5036711652 @default.
• W1581947446 creator A5047894137 @default.
• W1581947446 creator A5084386900 @default.
• W1581947446 creator A5087791435 @default.
• W1581947446 creator A5090366405 @default.
• W1581947446 date "2003-01-01" @default.
• W1581947446 modified "2023-10-18" @default.
• W1581947446 title "Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive traet" @default.
• W1581947446 cites W1575752211 @default.
• W1581947446 cites W1720669243 @default.
• W1581947446 cites W1925251592 @default.
• W1581947446 cites W1940904684 @default.
• W1581947446 cites W1970653863 @default.
• W1581947446 cites W1976549979 @default.
• W1581947446 cites W1993412356 @default.
• W1581947446 cites W1994405616 @default.
• W1581947446 cites W2033810905 @default.
• W1581947446 cites W2037206904 @default.
• W1581947446 cites W2037911272 @default.
• W1581947446 cites W2046545759 @default.
• W1581947446 cites W2049213793 @default.
• W1581947446 cites W2056884506 @default.
• W1581947446 cites W2070805755 @default.
• W1581947446 cites W2072751488 @default.
• W1581947446 cites W2079710223 @default.
• W1581947446 cites W2085635201 @default.
• W1581947446 cites W2085916839 @default.
• W1581947446 cites W2096368687 @default.
• W1581947446 cites W2110863884 @default.
• W1581947446 cites W2119794300 @default.
• W1581947446 cites W2121623797 @default.
• W1581947446 cites W2122645942 @default.
• W1581947446 cites W2128793386 @default.
• W1581947446 cites W2157408208 @default.
• W1581947446 cites W2185231599 @default.
• W1581947446 cites W2206044524 @default.
• W1581947446 cites W2319008999 @default.
• W1581947446 cites W2395630428 @default.
• W1581947446 cites W2411763563 @default.
• W1581947446 cites W2412316960 @default.
• W1581947446 cites W2438477177 @default.
• W1581947446 cites W2465259677 @default.
• W1581947446 cites W269361911 @default.
• W1581947446 cites W3149930582 @default.
• W1581947446 cites W4230922890 @default.
• W1581947446 cites W4318964464 @default.
• W1581947446 cites W1998630405 @default.
• W1581947446 doi "https://doi.org/10.3748/wjg.v9.i3.495" @default.
• W1581947446 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4621568" @default.
• W1581947446 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12632504" @default.
• W1581947446 hasPublicationYear "2003" @default.
• W1581947446 type Work @default.
• W1581947446 sameAs 1581947446 @default.
• W1581947446 citedByCount "78" @default.
• W1581947446 countsByYear W15819474462012 @default.
• W1581947446 countsByYear W15819474462013 @default.
• W1581947446 countsByYear W15819474462014 @default.
• W1581947446 countsByYear W15819474462015 @default.
• W1581947446 countsByYear W15819474462016 @default.
• W1581947446 countsByYear W15819474462017 @default.
• W1581947446 countsByYear W15819474462018 @default.
• W1581947446 countsByYear W15819474462019 @default.
• W1581947446 countsByYear W15819474462020 @default.
• W1581947446 countsByYear W15819474462021 @default.
• W1581947446 countsByYear W15819474462022 @default.
• W1581947446 countsByYear W15819474462023 @default.
• W1581947446 crossrefType "journal-article" @default.
• W1581947446 hasAuthorship W1581947446A5016514981 @default.
• W1581947446 hasAuthorship W1581947446A5020302124 @default.
• W1581947446 hasAuthorship W1581947446A5026731219 @default.
• W1581947446 hasAuthorship W1581947446A5036711652 @default.
• W1581947446 hasAuthorship W1581947446A5047894137 @default.
• W1581947446 hasAuthorship W1581947446A5084386900 @default.
• W1581947446 hasAuthorship W1581947446A5087791435 @default.
• W1581947446 hasAuthorship W1581947446A5090366405 @default.
• W1581947446 hasBestOaLocation W15819474461 @default.
• W1581947446 hasConcept C121608353 @default.
• W1581947446 hasConcept C126322002 @default.
• W1581947446 hasConcept C141071460 @default.
• W1581947446 hasConcept C203014093 @default.
• W1581947446 hasConcept C22070199 @default.
• W1581947446 hasConcept C2776283816 @default.
• W1581947446 hasConcept C2777701055 @default.
• W1581947446 hasConcept C2777863537 @default.
• W1581947446 hasConcept C71924100 @default.
• W1581947446 hasConcept C90924648 @default.
• W1581947446 hasConceptScore W1581947446C121608353 @default.
• W1581947446 hasConceptScore W1581947446C126322002 @default.
• W1581947446 hasConceptScore W1581947446C141071460 @default.
• W1581947446 hasConceptScore W1581947446C203014093 @default.
• W1581947446 hasConceptScore W1581947446C22070199 @default.
• W1581947446 hasConceptScore W1581947446C2776283816 @default.
• W1581947446 hasConceptScore W1581947446C2777701055 @default.

• next